Each tablet contains Methylcobalamin IP 1500 mcg and Pregabalin IP 75 mg.

Meconerv-P SR Tablets combine the neurotrophic benefits of Methylcobalamin with the analgesic action of Pregabalin to provide effective management of neuropathic pain. The formulation helps relieve nerve pain, supports nerve regeneration, promotes myelin synthesis, and improves overall neurological function in patients with peripheral neuropathic disorders.

Meconerv-P SR Tablets are indicated for the treatment of neuropathic pain.

Meconerv-P SR Tablets contain Pregabalin and Methylcobalamin, which provide complementary mechanisms for managing neuropathic pain. Pregabalin binds with high affinity to the alpha2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing calcium influx into nerve terminals and decreasing the release of excitatory neurotransmitters involved in pain transmission. This action contributes to its analgesic and anticonvulsant effects, helping alleviate neuropathic pain. Methylcobalamin, the active form of Vitamin B12, is essential for cell growth, hematopoiesis, nucleoprotein synthesis, and myelin sheath formation. It promotes nerve cell regeneration, supports repair of damaged peripheral nerves, and improves nerve conduction, thereby contributing to long-term neurological recovery.

The recommended dose is one tablet twice daily, or as directed by the physician.

Meconerv-P SR Tablets are contraindicated in patients with known hypersensitivity to Pregabalin, Methylcobalamin, or any component of the formulation.